CrossChx, a Columbus, Ohio-based provider of a solution for global patient identification, raised $15m in Series B funding.
The round was led by new investor Khosla Ventures and current investor Drive Capital. In conjunction with the funding, Keith Rabois, partner at Khosla Ventures, will join CrossChx’s board of directors as an observer.
The company, which has raised more than $20m in total funding, intends to use the funds to expand their customer base, triple staff, and develop its mobile platform.
Founded in 2012 by CEO Sean Lane and President Brad Mascho, CrossChx provides a proprietary identity resolution system that instantly verifies a patient’s identity and links them to their medical benefits to ensure the right person receives the right care. The solution has verified more than two million patient visits to date, and is deployed in more than 100 hospitals across eight states, and plans to be nationwide by the end of the year.